Want to join the conversation?
$MDT and $QCOM's unit Qualcomm Life announced a global, multi-year collaboration to jointly develop future generation continuous glucose monitoring (CGM) systems that aim to improve health outcomes for people with diabetes. The companies intend to enable more informed care, especially for those who do not have control of their diabetes today.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.